Zobrazeno 1 - 10
of 15
pro vyhledávání: '"N A, Tiukavkina"'
Publikováno v:
Klinicheskaia meditsina. 84(7)
Thirty-two patients with coronary heart disease (CHD)--exertional angina and postinfarction cardiosclerosis with dislipidemia--were treated with dicvertin (2,3-dihydro-3,5,7-trihydroxi-2(3,4-dihydroxiphenyl)-4H-1-benzopyran-4-on), a Russian antioxida
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 68(2)
Rats with model cerebral ischemia were treated over 5 days with acetylsalicylic acid (in a single daily dose of 50 mg/kg via a gastric tube). This treatment decreased the level of platelet aggregation, while producing no statistically significant eff
Autor:
M B, Plotnikov, D M, Plotnikov, V M, Alifirova, O I, Aliev, M Iu, Maslov, A S, Vasil'ev, N A, Tiukavkina
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 104(12)
Patients with stages I and II of vascular encephalopathy developing on the background of atherosclerosis were treated with ascovertin during 21 days. Ascovertin is a complex of flavonoid dihydroquercetin and ascorbic acid. The study group included 21
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 62(6)
In experiments in vitro on a model of the syndrome of increased blood viscosity dikvertin reduced blood viscosity, weakened aggregation of red cells and raised their property of becoming distorted. A mixture of dikvertin and ascorbic acid improved th
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 128(9)
Publikováno v:
Voprosy pitaniia. (6)
Information about types of vegetative raw material for flavonoid dihydroquercetin manufacture are given. Data of a wide spectrum of biological activity of dihydroquercetin are systematized. Two directions of use dihydroquercetin in food industry: as
Publikováno v:
Biofizika. 41(3)
The effect of dihydroquercetin on peroxidation process of liposome membranes from egg phospholipids induced by ferrous sulfate or Fe(2+)-ascorbate system was studied. It was shown that dihydroquercetin antioxidant activity matches antioxidant activit
Autor:
I A, Rulenko, N A, Tiukavkina, I A, Radaeva, Iu A, Kolesnik, L A, Ostroukhova, S P, Shul'kina
Publikováno v:
Voprosy pitaniia. (3)
Autor:
L I, Ol'binskaia, Zh M, Sizova, N A, Tiukavkina, V L, Beloborodov, E E, Kosilova, T A, Kobeleva
Publikováno v:
Kardiologiia. 30(12)
Bonnecor was tested for its antiarrhythmic activity in patients with acute myocardial infarction in the first 24 hours of the disease complicated by arrhythmias as ventricular premature beats (VPB). Proceeding from the comparison of its clinical effi
Autor:
L G, Lozinskiĭ, I P, Zamotaev, E M, Zeltyn'-Abramov, V A, Orlov, V L, Beloborodov, E E, Kosilova, M A, Zalesskaia, N A, Tiukavkina
Publikováno v:
Farmakologiia i toksikologiia. 53(3)
The clinical pharmacokinetics and the effect of bonnecor on parameters of the pharmacodynamics were studied in 53 patients with cardiac rhythm disorders, including 23 patients in the acute period of myocardial infarction. At intravenous administratio